Cannabis-Psychosis Link Was 11 Times Stronger in Adolescents Than Young Adults
Cannabis use during adolescence was associated with an 11-fold psychosis risk, but no significant risk during young adulthood, suggesting a critical vulnerability window.
Quick Facts
What This Study Found
Among 11,363 Ontario youth, cannabis use was associated with 11.2-fold increased psychosis risk during adolescence (12-19) but only non-significant 1.3-fold during young adulthood (20-33). Restricting to hospitalizations/ER: 26.7-fold risk in adolescents.
Key Numbers
N=11,363. Adolescence: aHR=11.2 (CI 4.6-27.3). Young adulthood: aHR=1.3 (CI 0.6-2.6). Hospitalizations only: adolescence aHR=26.7 (CI 7.7-92.8).
How They Did This
Population-based cohort linking 2009-2012 survey data with Ontario universal healthcare records through 2018. N=11,363 aged 12-24 with no prior psychotic disorder.
Why This Research Matters
One of the strongest demonstrations of age-dependent psychosis risk, using population data and healthcare records. The dramatically higher adolescent risk has direct prevention implications.
The Bigger Picture
The stronger associations compared to older studies may reflect increasing cannabis potency, providing modern, high-potency-era evidence for the neurodevelopmental theory.
What This Study Doesn't Tell Us
Observational. Single baseline cannabis measure. Possible confounding. Wide confidence intervals for hospitalization analysis.
Questions This Raises
- ?Does increasing potency explain stronger associations than older research?
- ?Is there a specific age threshold below which psychosis risk jumps?
Trust & Context
- Key Stat:
- Adolescent cannabis users: 11x psychosis risk; young adults: no significant increase
- Evidence Grade:
- Large population-based cohort with universal healthcare outcome data, though observational.
- Study Age:
- Published in 2024 with 2009-2012 baseline followed through 2018.
- Original Title:
- Age-dependent association of cannabis use with risk of psychotic disorder.
- Published In:
- Psychological medicine, 54(11), 2926-2936 (2024)
- Authors:
- McDonald, André J(8), Kurdyak, Paul(3), Rehm, Jürgen(12), Roerecke, Michael, Bondy, Susan J
- Database ID:
- RTHC-05536
Evidence Hierarchy
Enrolls participants and follows them forward in time.
What do these levels mean? →Frequently Asked Questions
Does cannabis cause psychosis in teenagers?
This study found 11-fold increased psychosis risk with adolescent cannabis use, though observational design cannot prove direct causation.
Is cannabis safer for adults than teenagers?
The data strongly suggest so. The psychosis association was 11x higher during adolescence than young adulthood.
Read More on RethinkTHC
- THC-amygdala-anxiety-brain
- anandamide-weed-withdrawal
- cannabinoid-receptors-recovery-time
- cannabis-developing-brain-teenagers
- cant-enjoy-anything-without-weed
- dopamine-recovery-after-quitting-weed
- endocannabinoid-system-explained-simply
- endocannabinoid-system-withdrawal
- nervous-system-weed-withdrawal-fight-flight
- teen-weed-use-under-18-effects-brain
- thc-brain-withdrawal
- thc-prefrontal-cortex-brain-effects
- weed-cortisol-stress-hormones
- weed-memory-loss-recovery
- weed-motivation-amotivational-syndrome
- weed-nervous-system-effects
- weed-reward-system-brain
Cite This Study
https://rethinkthc.com/research/RTHC-05536APA
McDonald, André J; Kurdyak, Paul; Rehm, Jürgen; Roerecke, Michael; Bondy, Susan J. (2024). Age-dependent association of cannabis use with risk of psychotic disorder.. Psychological medicine, 54(11), 2926-2936. https://doi.org/10.1017/S0033291724000990
MLA
McDonald, André J, et al. "Age-dependent association of cannabis use with risk of psychotic disorder.." Psychological medicine, 2024. https://doi.org/10.1017/S0033291724000990
RethinkTHC
RethinkTHC Research Database. "Age-dependent association of cannabis use with risk of psych..." RTHC-05536. Retrieved from https://rethinkthc.com/research/mcdonald-2024-agedependent-association-of-cannabis
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.